Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

New series of thrombin inhibitors claimed by Thomae

April 19, 1996

SKB discloses NK3 antagonists in patent literature

April 19, 1996

Nikken Chemicals describes antiallergy agents

April 19, 1996

Abbott claims new 5-LO inhibitors

April 19, 1996

Two novel series of LTB4 antagonists from Boehringer Ingelheim

April 19, 1996

Leukotriene D4 antagonists reported by Leo Denmark

April 19, 1996

SKB reports calcium antagonists for stroke

April 19, 1996

New Takeda compounds suppress increased vascular permeability

April 19, 1996

Lilly reports cannabinoid receptor antagonists

April 19, 1996

BASF reports dopamine D3 ligands

April 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...